Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites
Abstract
Sensitive rapid anti-HCV assays are appropriate and feasible for high-prevalence, high-risk populations such as PWID, who can be reached through social service settings such as syringe exchange programs and methadone maintenance treatment programs.
Keywords
hepatitis c
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
u.s. gov't
adult
female
male
adolescent
aged
middle aged
united states / epidemiology
young adult
P.H.S.
Multicenter Study
sensitivity and specificity
population surveillance
substance abuse
intravenous / complications
clinical laboratory techniques / methods*
hiv infections / immunology
hiv infections / virology
hepatitis c / diagnosis*
bryce d smith
hepatitis c antibodies / blood*
mass screening / methods
pmid:21921221
doi:10.1093/cid/cir499
eyasu teshale
elizabeth a dinenno
clinical laboratory techniques / standards
hiv / immunology
hiv infections / diagnosis*
hepacivirus / immunology*
hepatitis c / immunology
hepatitis c / virology
chronic / diagnosis
chronic / immunology
chronic / virology
saliva / virology
Access
Citation
ID:
113941
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
113941
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet
